BRWM
IMMU

B. Riley Wealth Management’s Immunomedics Inc IMMU Stock Holding History

B. Riley Wealth Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,900
Closed -$209K – 551
2020
Q2 		$209K Sell
5,900
-7,550
-56% -$221K 0.02% 367
2020
Q1 		$181K Buy
13,450
+2,550
+23% +$42.9K 0.02% 444
2019
Q4 		$231K Buy
+10,900
New +$192K 0.03% 338
2019
Q2 		– Sell
-40,125
Closed -$771K – 448
2019
Q1 		$771K Buy
40,125
+600
+2% +$9.67K 0.13% 160
2018
Q4 		$564K Sell
39,525
-7,089
-15% -$141K 0.12% 176
2018
Q3 		$971K Buy
+46,614
New +$1.1M 0.24% 95
2015
Q3 		– Sell
-4,070
Closed -$16K – 857
2015
Q2 		$16K Buy
+4,070
New +$16.6K 0.01% 658

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

B. Riley Wealth Management's IMMU Position: Q3 2020 in Review

B. Riley Wealth Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 5,900 shares — an estimated $209K sold.

B. Riley Wealth Management first reported a position in IMMU in Q2 2015 and held it in 7 quarters. The position peaked at $971K in Q3 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • B. Riley Wealth Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • B. Riley Wealth Management sold 5,900 Immunomedics Inc shares in Q3 2020, an estimated $209K.
  • B. Riley Wealth Management first reported a position in Immunomedics Inc in Q2 2015 and held it in 7 quarters.
  • B. Riley Wealth Management's Immunomedics Inc position peaked at $971K in Q3 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on B. Riley Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.